What is the average price target for CARLSMED INC (CARL) stock?
11 analysts have analysed CARL and the average price target is 19.99 USD. This implies a price increase of 123.62% is expected in the next year compared to the current price of 8.94.
CARLSMED INC (CARL) Forecast, Price Target & Analyst Ratings
NASDAQ:CARL • US14280C1053
Current stock price
8.94 USD
-0.78 (-8.02%)
At close:
9.11 USD
+0.17 (+1.9%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CARLSMED INC (CARL).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Apr 30, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.40
- Revenue Estimate
- 15.284M
Price Target Details & History
Consensus Price Target and Range
Mean target
$19.99
Upside
+ 123.62%
From current price of $8.94 to mean target of $19.99, Based on 11 analyst forecasts
Low
$17.17
Median
$19.38
High
$25.20
Price Target Revisions
1 Month
1.03%
3 Months
0.00%
Price Target Summary
11 Wall Street analysts provided a forecast for the next 12 months for CARL. The average price target is 19.99 USD. This implies a price increase of 123.62% is expected in the next year compared to the current price of 8.94.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
85.45%
CARL was analyzed by 11 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about CARL.
In the previous month the buy percentage consensus was at a similar level.
CARL was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-09 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-12-15 | BTIG | Reiterate | Buy -> Buy |
| 2025-11-07 | BTIG | Maintains | Buy -> Buy |
| 2025-11-07 | Truist Securities | Reiterate | Buy -> Buy |
| 2025-08-18 | Truist Securities | Initiate | Buy |
| 2025-08-18 | Goldman Sachs | Initiate | Buy |
| 2025-08-18 | Piper Sandler | Initiate | Overweight |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 30, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.40
- Revenue Estimate
- 15.284M
- Revenue Q2Q
- 50.00%
- EPS Q2Q
- N/A
- Number of Analysts
- 7
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
4.71%
EPS (1 Month)
0.00%
EPS (3 Months)
4.85%
Next Earnings Summary
CARL is expected to report earnings on 4/30/2026. The consensus EPS estimate for the next earnings is -0.4 USD and the consensus revenue estimate is 15.28M USD.
The next earnings revenue estimate has been revised upward by 4.71% in the past 3 months.
Full Analyst Estimates 2026 - 2028
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 27.556M | 54.33M 97.16% | 101.022M 85.94% | 74.263M -26.49% | 104.51M 40.73% | 144.67M 38.43% | |
| EBITDA YoY % growth | -37.046M | -47.85M -29.16% | -60.72M -26.90% | -37.605M 38.07% | -32.24M 14.26% | -13.04M 59.55% | |
| EBIT YoY % growth | -37.182M | -48M -29.09% | -61M -27.08% | -45.822M 24.88% | -44.792M 2.25% | -34.761M 22.39% | |
| Operating Margin | -134.93% | -88.35% | -60.38% | -61.70% | -42.86% | -24.03% | |
| EPS YoY % growth | N/A | N/A | N/A | -1.61 34.36% | -1.56 2.79% | -1.17 25.20% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.40 | -0.42 | -0.41 -3.53% | -0.38 -17.30% | -0.39 1.79% | -0.40 4.59% | -0.40 3.94% | -0.42 -11.41% |
| Revenue Q2Q % growth | 15.284M 50.00% | 17.642M 46.01% | 19.198M 46.84% | 22.16M 46.13% | 21.933M 43.50% | 24.531M 39.05% | 26.068M 35.78% | 31.137M 40.51% |
| EBITDA Q2Q % growth | -9.816M -72.82% | -9.751M -52.36% | -9.602M -8.38% | -8.435M 6.69% | -7.163M 27.03% | -7.388M 24.23% | -7.193M 25.09% | -7.814M 7.36% |
| EBIT Q2Q % growth | -11.325M -97.98% | -11.946M -83.78% | -11.851M -31.09% | -10.701M -14.81% | -11.013M 2.75% | -11.238M 5.92% | -11.095M 6.38% | -11.665M -9.01% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
15.05%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
41.70%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
17.22%
EBIT Next 5 Year
N/A
CARLSMED INC / CARL Forecast FAQ
Can you provide the upcoming earnings date for CARLSMED INC?
CARLSMED INC (CARL) will report earnings on 2026-04-30.
Can you provide the consensus estimates for CARLSMED INC next earnings?
The consensus EPS estimate for the next earnings of CARLSMED INC (CARL) is -0.4 USD and the consensus revenue estimate is 15.28M USD.
How do analysts rate CARLSMED INC (CARL)?
The consensus rating for CARLSMED INC (CARL) is 85.4545 / 100 . This indicates that analysts generally have a positive outlook on the stock.